NCT00686127

Symptom Management After Breast Cancer Surgery

A Randomized, Double-Blind, Placebo-Controlled Trial (RDBPCT) of the Effectiveness of the Lidocaine Patch in the Management of Neuropathic Pain After Breast Cancer Surgery

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: University of California, San Francisco · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women who wear the lidocaine patch will report a decrease in pain and decreased interference with function compared to women who wear the placebo patch.

Conditions

• Neuropathic Pain
• Postmastectomy Pain

Interventions

Type	Name	Description
DRUG	Lidoderm patch	1 patch was applied topically to the affected site(s) for 12 hours each day.
DRUG	Placebo patch	1 patch was applied topically to the affected site(s) for 12 hours each day.

Timeline

• Start date: 2003-09-01
• Primary completion: 2007-12-01
• Completion: 2007-12-01
• First posted: 2008-05-29
• Last updated: 2018-06-28
• Results posted: 2014-05-01

Locations

1 site across 1 country: United States